It has been reported that green tea consumption reduces the risk of coronary artery disease and cardiac events. Catechin is a major constituent of Japanese green tea and an antioxidant. Lipids and oxidization of low-density lipoprotein cholesterol (LDL-C) play important roles in atherosclerosis. Therefore, we evaluated the effect of catechin intake on the lipid profile and plasma oxidized LDL. The study population consisted of 40 healthy adult volunteers (10 men, 30 women). Catechin was extracted from green tea leaves. The subjects were randomly divided into two groups, a catechin group (n = 29) and a control group (n = 11). In the catechin group, catechin (500 mg: equivalent to 6 or 7 cups of green tea) was administered orally. Venous blood samples were obtained before eating a meal at the start and after 4 weeks without any lifestyle modification. Plasma oxidized LDL assay was performed with a sandwich-type enzyme immunoassay using anti-oxidized phosphatidylcholine monoclonal antibody. The baseline lipid profiles and tea consumptions were similar between the two groups. Plasma oxidized LDL was significantly decreased after catechin administration (from 9.56 ± 9.2 to 7.76 ± 7.7 U/mL, P = 0.005), while plasma LDL-C, triglyceride, and HDL-C concentrations did not change. Catechin decreased the plasma oxidized LDL concentration without significant change in plasma LDL concentration. The mechanism of the beneficial effects of green tea on coronary artery disease might result from a decrease in plasma oxidized LDL. (Int Heart J 2007; 48: 725-732) 
to prevent atherosclerosis. Up to now, several reports have indicated that antioxidant intake is inversely associated with the incidence of coronary artery disease. [3] [4] [5] [6] [7] [8] In France, the mortality rate from coronary heart disease is low in spite of a high intake of saturated fat. It is believed this paradox is attributable to a high consumption of red wine, which contains phenolic substances that are antioxidants. Other experiments have demonstrated that red wine inhibits the oxidation of LDL. 9, 10) The rate of cigarette smoking is very high in Japan. Nonetheless, the mortality rate from coronary artery disease is lower than in Western countries. Japanese people have in the past and continue today to consume a large amount of green tea. In previous studies, we and other investigators have reported that green tea consumption reduced the risk of coronary artery disease. [11] [12] [13] Moreover, a recent prospective study demonstrated that green tea consumption is associated with reduced mortality due to cardiovascular disease.
14) The effect of green tea on cardiovascular disease is believed to be due to its antioxidant effects.
It has recently become possible to measure circulating oxidized LDL (Ox-LDL). 15, 16) Two studies have reported the effects of statins on Ox-LDL. 17, 18) Catechins are the major constituent of green tea and are antioxidants. To the best of our knowledge, there are no reports concerning the effects of catechins on the levels of circulating Ox-LDL. In the present study, we have examined the effects of catechin intake on circulating Ox-LDL.
METHODS
The present study was a prospective trial. The subjects included 40 healthy adult volunteers (10 men, 30 women) who were randomly divided into two groups; a catechin group (n = 29) and a control group (n =11). The study was approved by the Institutional Review Board of our hospital and informed consent was obtained from all subjects. Information on medical history and life-style including smoking status, consumption of red wine and green tea, antioxidant vitamin use, and dietary intake of selected foods was obtained from the subjects through interviews. We used capsulized Polyphenon 70S (Food Research Laboratories, Mitsui Norin Co., Shizuoka, Japan). Polyphenon 70S, which is extracted from green tea leaves with hot water, contains 35.6% epigallocatechin gallate, 10.2% epicatechin gallate, 3.8% gallocatechin gallate, 0.6% catechin gallate, 15.0% epigallocatechin, and 8.7% epicatechin. In the catechin group, each subject orally ingested Polyphenon 70S capsules containing 500 mg of catechin after a meal once a day. Five hundred mg of catechin is equal to the dosage contained in 6 or 7 cups of green tea. At the start and after 4 weeks, venous blood samples were obtained after a 12-hour fast with no alcohol intake in the previous 24 hours. Tobacco use was also prohibited in the morning of blood examination. Blood Vol 48 No 6 samples were collected in EDTA-containing tubes and centrifuged at 3000g for 15 minutes at room temperature within 20 minutes. Plasma was collected in antioxidant-containing tubes and stored at 0°C. The concentrations of plasma total cholesterol (TC), triglycerides (TG), LDL-C, high-density lipoprotein cholesterol (HDL-C), lipoprotein (a)(Lp (a)), and Ox-LDL were measured. Laboratory assays: Plasma TC, TG, LDL-C, HDL-C and Lp (a) concentrations were measured using established methodologies with commercial kits. Plasma Ox-LDL was assayed using a Kyowa Medex MX kit (Kyowa Medex Inc. Tokyo), which is a sandwich-type enzyme immunoassay using anti-oxidized phosphatidylcholine monoclonal antibody (DLH3) and anti-human apolipoprotein-B antibody. 15, 16) Statistical analysis: Data are presented as the mean ± SD. The KolmogorovSmirnov test was used to determine whether or not the data were normally distributed. If the data were normally distributed, the unpaired t-test was used to compare the two groups. Data that were not normally distributed were compared using the Mann-Whitney U-test. Discontinuous parameters were compared by χ 2 analysis. The paired t-test was used to analyze the changes in lipid concentration. A value of P < 0.05 was considered statistically significant.
RESULTS

Baseline characteristics:
The baseline characteristics of the catechin group and control group are summarized in Table I . The frequencies of coronary risk factors and green tea consumption were not significantly different between the two groups. The plasma Ox-LDL and lipid concentrations were similar in the two groups at baseline. None of the subjects were taking antioxidant supplements, and none consumed red wine on a regular basis. Changes in plasma lipid and Ox-LDL concentrations: The changes in plasma lipid and Ox-LDL concentrations are shown in Table II . The plasma TC, LDL-C, HDL-C, TG, and Lp(a) concentrations did not change in either group. Although the plasma LDL-C concentration did not change (from 102.3 ± 25.7 to 101.0 ± 24.5 mg/dL: P = 0.530), the plasma Ox-LDL concentration decreased significantly after intervention in the catechin group (from 9.56 ± 9.18 to 7.77 ± 7.70 U/ mL; P = 0.005). Furthermore, the Ox-LDL (mg/dL)/LDL-C (U/mL) % ratio significantly decreased in the catechin group (from 9.0 ± 6.7 to 7.4 ± 5.9 : P = 0.001) (Figure) . The plasma Ox-LDL concentration and Ox-LDL/LDL-C % ratio did not change after intervention in the control group (from 13.33 ± 9.22 to 13.84 ± 10.06 U/mL: P = 0.607 and 11.1 ± 5.2 to 10.5 ± 5.5 ; P = 0.447, respectively). 
DISCUSSION
The present study is the first report to demonstrate the inhibitory effects of catechin on circulating Ox-LDL using a Kyowa Medex MX kit. Administration of 500 mg of catechin per day resulted in a 11.7% reduction in the plasma Ox-LDL concentration. Since catechin was not effective at lowering the plasma LDL-C concentration, it is thought that the Ox-LDL lowering effect of catechin does not depend on an LDL-C lowering effect, but rather its antioxidizing activity. Sano, et al reported that the daily intake of green tea was 5.9 cups/day in patients without coronary artery disease, and they suggested it had an antioxidant Figure. Changes in Ox-LDL (mg/dL)/LDL-C(U/mL) % ratio in the catechin group. Ox-LDL(mg/dL)/LDL-C(U/mL) ratio was significantly decreased in the catechin group (9.0 ± 6.7 to 7.4 ± 5.9 : P = 0.001). effect in vivo. 13) The results of the present study showed that 500 mg of catechin, which is equivalent to 6 cups of green tea per day, reduced circulating Ox-LDL.
The origin and action of the circulating Ox-LDL is still unclear. Pathophysiological studies have demonstrated that Ox-LDL is present in atherosclerotic lesions. 19, 20) It is generally recognized that circulating Ox-LDL originates in atherosclerotic lesions. It is also possible that in the blood LDL-C is converted to Ox-LDL by free radicals or other substances. Ox-LDL exerts a variety of effects that could be atherogenic, including chemotaxis of monocytes, up-regulation of endothelial adhesion molecules, stimulation of growth factor, chemokine expression, and proliferative effects on smooth muscle cells and monocytes. Although it is certain that the oxidative modification of LDL-C plays an important role in the development of atherosclerosis, the efficacy of antioxidant therapies in humans has not yet been clearly established. Taking into consideration the previous reports, green tea consumption seems to be associated with a reduced incidence of coronary artery disease. The results of the present study also demonstrate that catechin consumption decreased the levels of circulating Ox-LDL. The beneficial effect of green tea on coronary artery disease is thought to result partially from a decrease in circulating Ox-LDL. In other words, the effect of green tea on coronary artery disease can be characterized by a decrease in circulating Ox-LDL.
Several methods for the measurement of circulating Ox-LDL have been established. Accumulating data support the importance of circulating Ox-LDL as a useful marker of atherosclerosis and coronary heart disease. [21] [22] [23] It is possible that variations in the measurements cause differences in the results. A monoclonal antibody (DLH3) generated by immunizing mice with a homogenate of human atheroma is used in the Kyowa Medex MX kit used in this study. It was reported that circulating Ox-LDL measured by DLH3 antibody was a predictor for future cardiovascular events. 24, 25) Recently, it was demonstrated that beta carotene, vitamin A, and vitamin E did not have any beneficial effects on mortality in meta-analysis. We could not find any reports concerning the effects of these antioxidant supplements on circulating Ox-LDL measured by DLH3 antibody. The circulating Ox-LDL measured by DLH3 antibody may reflect the impact of antioxidative therapy. In the future, the effects of other antioxidative agents on circulating Ox-LDL should be evaluated.
CONCLUSION
The present report documents a novel observation that cathechins decrease the plasma Ox-LDL concentration without any significant change in plasma LDL concentration. The beneficial effects of green tea on coronary artery disease Vol 48 No 6 might result from a decrease in plasma Ox-LDL.
